• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌前上皮细胞中β2-微球蛋白的表达

Expression of beta 2-microglobulin by premalignant epithelium.

作者信息

Petersen B L, Petersen C L, Braendstrup O, Mouritsen S, Engel A M, Svane I M, Werdelin O

机构信息

Department of Pathology, KAS Glostrup, Denmark.

出版信息

APMIS. 1993 Jul;101(7):529-36. doi: 10.1111/j.1699-0463.1993.tb00142.x.

DOI:10.1111/j.1699-0463.1993.tb00142.x
PMID:8398092
Abstract

Many human tumors express low amounts of HLA class I molecules relative to the normal cells from which they are derived. From experimental work it is clear that the malignant behavior of a tumor cell may depend on its MHC class I expression. Therefore, it is of obvious interest to study the HLA class I expression of human tumors in their various stages. We have studied the HLA class I expression by the cells in premalignant epithelial lesions and invasive carcinoma of the bladder and uterine cervix using immunoperoxidase staining for beta 2-microglobulin of paraffin-embedded tissue. We here assume that beta 2-microglobulin expression by malignant and premalignant cells equals HLA class I expression. Thirty-two of the 36 invasive tumors expressed less overall beta 2-microglobulin than cells from the normal epithelium. In contrast, approximately two-thirds of 34 premalignant bladder epithelia and 47 premalignant cervix epithelia displayed higher overall beta 2-microglobulin expression than the normal epithelium. Thus, a systematic large-scale elimination of HLA class I high-expressing tumor cell variants may take place only after the tumor penetrates the basement membrane.

摘要

与产生它们的正常细胞相比,许多人类肿瘤表达的HLA I类分子数量较少。从实验工作中可以清楚地看出,肿瘤细胞的恶性行为可能取决于其MHC I类分子的表达。因此,研究人类肿瘤在不同阶段的HLA I类分子表达显然具有重要意义。我们使用免疫过氧化物酶法对石蜡包埋组织中的β2-微球蛋白进行染色,研究了膀胱和子宫颈癌前上皮病变及浸润性癌中细胞的HLA I类分子表达。我们在此假设恶性和癌前细胞的β2-微球蛋白表达等同于HLA I类分子表达。36例浸润性肿瘤中有32例总体β2-微球蛋白表达低于正常上皮细胞。相比之下,34例癌前膀胱上皮和47例癌前子宫颈上皮中约三分之二的总体β2-微球蛋白表达高于正常上皮。因此,只有在肿瘤穿透基底膜后,才可能系统性地大规模清除高表达HLA I类分子的肿瘤细胞变体。

相似文献

1
Expression of beta 2-microglobulin by premalignant epithelium.癌前上皮细胞中β2-微球蛋白的表达
APMIS. 1993 Jul;101(7):529-36. doi: 10.1111/j.1699-0463.1993.tb00142.x.
2
HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.宫颈癌前病变和恶性病变中的HLA I类表达及HPV - 16序列
Tissue Antigens. 1993 Feb;41(2):65-71. doi: 10.1111/j.1399-0039.1993.tb01981.x.
3
Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.子宫颈癌前病变和鳞状癌中特定主要组织相容性复合体抗原表达的改变。
Acta Obstet Gynecol Scand. 2003 Dec;82(12):1146-52. doi: 10.1046/j.1600-0412.2003.00252.x.
4
[Loss of beta 2 microglobulin from the surface of "dysplastic" and malignant epithelial cells of the uterine cervix].[子宫颈“发育异常”及恶性上皮细胞表面β2微球蛋白的缺失]
Zentralbl Gynakol. 1989;111(11):744-8.
5
Up-regulation of HLA-G expression in cervical premalignant and malignant lesions.宫颈癌前病变和恶性病变中HLA-G表达上调。
Tissue Antigens. 2011 Mar;77(3):218-24. doi: 10.1111/j.1399-0039.2010.01607.x.
6
Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.HLA I类和II类抗原在宫颈原位癌、浸润癌和转移癌中的表达变化。
Exp Mol Med. 2001 Sep 30;33(3):136-44. doi: 10.1038/emm.2001.24.
7
[Cytomorphologic and morphometric characteristics of the endocervical epithelium during malignant degeneration].[宫颈上皮恶性退变过程中的细胞形态学和形态测量学特征]
Vopr Onkol. 1989;35(6):715-21.
8
Beta-2-microglobulins as a differentiation marker in bladder cancer.β2-微球蛋白作为膀胱癌的一种分化标志物。
J Urol. 1986 Dec;136(6):1197-200. doi: 10.1016/s0022-5347(17)45281-5.
9
Differential regulation of HLA-DQ expression by keratinocytes and Langerhans cells in normal and premalignant cervical epithelium.正常和癌前宫颈上皮中角质形成细胞和朗格汉斯细胞对HLA-DQ表达的差异调节
Tissue Antigens. 1998 Sep;52(3):286-93. doi: 10.1111/j.1399-0039.1998.tb03046.x.
10
Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.主要组织相容性复合体在乳腺癌发生中的状态及其与细胞凋亡的关系。
Hum Pathol. 2003 Dec;34(12):1283-9. doi: 10.1016/j.humpath.2003.06.001.

引用本文的文献

1
Reduced expression of members of the mhc-i antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China.在中国新疆地区,维吾尔族宫颈癌患者 MHC-I 抗原加工机制成员的表达降低。
Curr Oncol. 2014 Feb;21(1):e67-74. doi: 10.3747/co.21.1595.
2
Clinical implication of HLA class I expression in breast cancer.乳腺癌中 HLA I 类分子表达的临床意义。
BMC Cancer. 2011 Oct 20;11:454. doi: 10.1186/1471-2407-11-454.
3
The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.
细胞毒性T淋巴细胞在肿瘤预防和免疫监视中的作用——来自正常和免疫缺陷小鼠的经验教训。
Med Oncol. 1999 Dec;16(4):223-38. doi: 10.1007/BF02785868.